Oral and Parenteral Therapy With Saperconazole (R 66905) of Invasive Aspergillosis in Normal and Immunocompromised Animals.

Antimicrobial Agents and Chemotherapy - United States
doi 10.1128/aac.33.12.2063
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Society for Microbiology

Related search

Saperconazole Therapy in a Rabbit Model of Invasive Aspergillosis.

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
1992English

Invasive Pulmonary Aspergillosis in Non-Immunocompromised Patients.

BMJ
1991English

A Report of 2 Cases of Disseminated Invasive Aspergillosis With Myocarditis in Immunocompromised Patients

Open Journal of Pathology
2013English

Combination Therapy With Isavuconazole and Micafungin for Treatment of Experimental Invasive Pulmonary Aspergillosis

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2017English

Combination Therapy With Terbinafine and Amphotericin B in a Rabbit Model of Experimental Invasive Aspergillosis

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2005English

Multiple Debulking Surgery and Triple Antifungal Therapy in Abdominal-Cardiac-Pulmonary Invasive Aspergillosis

OnCOReview
Oncology
2018English

Saperconazole Therapy of Murine Disseminated Candidiasis: Efficacy and Interactions With Amphotericin B.

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
1994English

A Case of Invasive Pulmonary Aspergillosis With AIDS Occurring Immediately After Initiating Antiretroviral Therapy

Kansenshogaku zasshi. The Journal of the Japanese Association for Infectious Diseases
Medicine
2018English

Diagnosis and Treatment of Invasive Pulmonary Aspergillosis in ICU

Nihon Shuchu Chiryo Igakukai zasshi
2008English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy